HistoIndex AI Analysis Confirms Fibrosis Improvement in D&D Pharmatech Phase 2 MASH Trial
HistoIndex's AI-based quantitative analysis confirmed significant liver fibrosis improvement in D&D Pharmatech's Phase 2 trial of zabopegdutide for MASH, reinforcing earlier histopathological findings.